The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
-
Published:2021-08
Issue:16-17
Volume:105
Page:6355-6367
-
ISSN:0175-7598
-
Container-title:Applied Microbiology and Biotechnology
-
language:en
-
Short-container-title:Appl Microbiol Biotechnol
Author:
Biernasiuk AnnaORCID, Berecka-Rycerz Anna, Gumieniczek Anna, Malm Maria, Łączkowski Krzysztof Z., Szymańska Jolanta, Malm Anna
Abstract
Abstract
Recently, the occurrence of candidiasis has increased dramatically, especially in immunocompromised patients. Additionally, their treatment is often ineffective due to the resistance of yeasts to antimycotics. Therefore, there is a need to search for new antifungals. A series of nine newly synthesized thiazole derivatives containing the cyclopropane system, showing promising activity against Candida spp., has been further investigated. We decided to verify their antifungal activity towards clinical Candida albicans isolated from the oral cavity of patients with hematological malignancies and investigate the mode of action on fungal cell, the effect of combination with the selected antimycotics, toxicity to erythrocytes, and lipophilicity. These studies were performed by the broth microdilution method, test with sorbitol and ergosterol, checkerboard technique, erythrocyte lysis assay, and reversed phase thin-layer chromatography, respectively. All derivatives showed very strong activity (similar and even higher than nystatin) against all C. albicans isolates with minimal inhibitory concentration (MIC) = 0.008–7.81 µg/mL Their mechanism of action may be related to action within the fungal cell wall structure and/or within the cell membrane. The interactions between the derivatives and the selected antimycotics (nystatin, chlorhexidine, and thymol) showed additive effect only in the case of combination some of them and thymol. The erythrocyte lysis assay confirmed the low cytotoxicity of these compounds as compared to nystatin. The high lipophilicity of the derivatives was related with their high antifungal activity. The present studies confirm that the studied thiazole derivatives containing the cyclopropane system appear to be a very promising group of compounds in treatment of infections caused by C. albicans. However, this requires further studies in vivo.
Key points
• The newly thiazoles showed high antifungal activity and some of them — additive effect in combination with thymol.
• Their mode of action may be related with the influence on the structure of the fungal cell wall and/or the cell membrane.
• The low cytotoxicity against erythrocytes and high lipophilicity of these derivatives are their additional good properties.
Graphical abstract
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference52 articles.
1. Abe H, Kikuchi S, Hayakawa K, Iida T, Nagahashi N, Maeda K, Sakamoto J, Matsumoto N, Miura T, Matsumura K, Seki N, Inaba T, Kawasaki H, Yamaguchi T, Kakefuda R, Nanayama T, Kurachi H, Hori Y, Yoshida T, Kakegawa J, Watanabe Y, Gilmartin AG, Richter MC, Moss KG, Laquerre SC (2011) Discovery of a highly potent and selective MEK inhibitor: GSK1120212 (JTP-74057 DMSO Solvate). ACS Med Chem Lett 2:320–324. https://doi.org/10.1021/ml200004g 2. Abu-Melha S, Edrees MM, Riyadh SM, Abdelaziz MR, Elfiky AA, Gomha SM (2020) Clean grinding technique: A facile synthesis and in silico antiviral activity of hydrazones, pyrazoles, and pyrazines bearing thiazole moiety against SARS-CoV-2 Main Protease (Mpro). Molecules 25:4565–4578. https://doi.org/10.3390/molecules25194565 3. Badiee P, Badali H, Boekhout T, Diba K, Moghadam AG, Hossaini Nasab A, Jafarian H, Mohammadi R, Mirhendi H, Najafzadeh MJ, Shamsizadeh A, Soltani J (2017) Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC Infect Dis 21; 17(1): 727–735. https://doi.org/10.1186/s12879-017-2825-7 4. Biernasiuk A, Szymańska J, Kustra A, Korona-Głowniak I, Malm A (2018) In vitro susceptibility of oral Candida albicans isolates to chlorhexidine. Acta Pol Pharm 75:795–802 5. Blanco AR, Nostro A, D’Angelo V, D’Arrigo M, Mazzone MG, Marino A (2017) Efficacy of a fixed combination of tetracycline, chloramphenicol, and colistimethate sodium for treatment of Candida albicans keratitis. Invest Ophthalmol vis Sci 58:4292–4298. https://doi.org/10.1167/iovs.17-22047
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|